Celebrating Success: A Look at GALVmed Achievements

is not a video entry

For small-scale livestock producers in the global south, a goat, cow, or flock of chickens are not just animals – they are the foundation of their livelihoods. Livestock provide food, income, and security, and losing them to preventable diseases can be devastating.

In a world where over a billion people depend on livestock, improving animal health is critical not only to protect individuals but also to ensure sustainable agricultural systems, food security and safety, and entire community’s well-being and progression.

GALVmed continues to collaborate with partners and key public and private stakeholders to transform the lives of small-scale producers across Africa and South Asia through improved animal health. Our approach remains the same: enhancing the availability, accessibility, awareness and adoption of high-quality veterinary medicines to reduce productivity and animal losses from preventable diseases. And how does this translate into tangible actions?

• Improving availability: By researching, improving and developing much needed animal health products and solutions suited to the needs of small-scale livestock producers.
• Increasing accessibility:  By easing barriers in the regulatory and policy environment ensuring the needed products reach the markets and are accessible and affordable to small-scale livestock producers.
• Increasing awareness and adoption: By using appropriate channels to reach the last mile providing information and veterinary medicines to small-scale livestock producers.  
• Increasing understanding: By providing practical data and information from the small-scale livestock producer field to measure impact and facilitate data-driven decisions.

Over the years, GALVmed through its partners, has implemented impactful programmes across Africa and South Asia, leading to significant achievements:

• 2.9 billion livestock vaccines, therapeutics and other animal health products sold to small-scale customers across Africa and South Asia, of which 1.3 billion doses were vaccines and the remainder therapeutics, parasite treatments and supplements (2014-2023).
• 6.2 million estimated cumulative annual customers served (2014-2023).

• 38.7 million livestock deaths averted saving the sector approximately of $359 million (2014-2023).
• Approximately $126 million in poultry deaths averted from Newcastle disease, excluding benefits derived from the project PREVENT (2014-2023).
• 16 animal health products taken to full development since 2010.
• A total of 19 products registered under the Mutual Recognition Procedure (MRP) to date.
• Over 100 publications disseminated.

GALVmed will continue to work closely with partners to make effective animal health products accessible across sub-Saharan Africa and South Asia, advancing our mission to safeguard livestock health to consequently improve human lives.